Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Ocrevus 300mg Injection
Manufacturer/Marketed By : ROCHE PRODUCTS INDIA PVT LTD
$3069.76 $2825.18
Sidmex Inovia offers bulk export supply of Ocrevus 300mg Injection (OCRELIZUMAB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents, cold-chain shipping and tenders:...
OCRELIZUMAB
Active Pharmaceutical Ingredient
Ocrevus 300mg Injection
$3,069.76
$2,825.18
Sidmex Inovia offers bulk export supply of Ocrevus 300mg Injection (OCRELIZUMAB) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Alburel 20 gm/100 ml Injection
Ocrevus 300mg injection is a monoclonal antibody used primarily for the treatment of multiple sclerosis (MS), specifically in patients with relapsing forms of MS and primary progressive MS. Its active ingredient, ocrelizumab, works by targeting and depleting specific B cells that are believed to contribute to the immune system's attack on the central nervous system. This action helps reduce disease activity and slow the progression of MS, improving the quality of life for many patients. Ocrevus infusion is generally administered every six months after the initial loading dose, providing convenient, long-term management of the condition. Ocrevus is generally considered safe when prescribed under the supervision of a healthcare provider, but like all medications, it carries certain risks. Patients may experience infusion-related reactions, which can range from mild to severe. It is also contraindicated in individuals who are allergic to ocrelizumab or any of its components, and it should not be used in patients with active infections or a history of certain viral infections. The cost of Ocrevus infusion varies based on location and healthcare provider, with the Ocrevus 300mg dose being a standard offering. Before starting treatment, it's important to discuss the potential risks, benefits, and the cost of Ocrevus infusion with your healthcare provider to determine if it’s the right option for your condition.
Active Pharmaceutical Ingredient
Uses
• Relapsing forms of multiple sclerosis (RMS)
• Early primary progressive multiple sclerosis (PPMS)
Benefits
Ocrevus 300mg injection is a powerful treatment for multiple sclerosis (MS), specifically for patients with relapsing forms and primary progressive MS. Its active ingredient, ocrelizumab, targets and depletes CD20-positive B cells, which are involved in the autoimmune attack on the nervous system in MS. By reducing the number of these B cells, Ocrevus helps to lower inflammation, prevent relapses, and slow the progression of disability. The therapeutic effects of Ocrevus include improved long-term outcomes, with reduced disease activity and a slower progression of neurological damage, particularly in patients with primary progressive MS, where treatment options were historically limited. Ocrevus 300mg infusion offers significant benefits in managing MS, improving patient quality of life, and providing a more manageable course of the disease.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Most Common Side Effects
• Sore throat and runny nose
• Flu
• Sinus infection
• Bronchitis (bronchial tube inflammation)
• Stomach and bowel infection (gastroenteritis)
• Respiratory tract infection
• Viral infection
• Conjunctivitis (discharge from the eye with itching, redness and swelling)
• Cough
• Formation of thick mucus in the nose, throat, or chest
• Low white blood cells
Common Side Effects
• Infusion-related reactions
• Skin infection (cellulitis)
• Herpes infection (cold sore or shingles)
How To Use
A doctor or nurse in a hospital or clinical setting will give it to you. It is given intravenously (into the vein). Do not self-administer the injection. Your doctor will decide the dose and duration of the treatment based on your disease severity, body weight, and other factors.
Safety Advice
• Breast Feeding: Limited information is available on using Ocrevus 300mg injection during breastfeeding. So, before starting the treatment, inform your doctor if you are breastfeeding. Contact your doctor for more information.
• Alcohol: It is unknown whether consuming alcohol while taking an Ocrevus 300mg injection is safe. Please speak with your physician.
• Liver: It is unknown whether Ocrevus 300mg injection is safe for patients with liver problems. Inform your physician if you have any liver disease before starting the treatment.
• Lungs: It is unknown whether Ocrevus 300mg injection is safe for patients with lung problems. Contact your doctor for more advice.
• Driving: It is unknown whether Ocrevus 300mg injection can affect the ability to drive or not. Consult your doctor before using the medicine.
• Pregnancy: Consult your healthcare provider if you plan to get pregnant. However, the medication has not been given to expectant mothers, and it should only be used when the projected advantages outweigh any possible hazards to the fetus.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.